CASI Pharmaceuticals CASIF
OTC CASIF
$0.10 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

CASI Pharmaceuticals (CASIF) Ending Cash Balance (2021 - 2025)

Updated

Analysis

CASI Pharmaceuticals (CASIF) Ending Cash Balance (2021 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 16.91 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 6.57 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 6.89 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 4.88 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 3.18 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 1.03 Bn
10 CASI Pharmaceuticals 2.06 Mn -18.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 5.63 Mn
Dec 31, 2024 13.47 Mn
Dec 31, 2023 17.08 Mn
Dec 31, 2022 47.11 Mn
Dec 31, 2021 38.70 Mn
API Access

CASI Pharmaceuticals Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=CASIF&period=max&api_key=YOUR_API_KEY